Palatin Technologies, Inc. (PTN)
NYSEAMERICAN: PTN · Real-Time Price · USD
20.90
-0.09 (-0.43%)
At close: Feb 27, 2026, 4:00 PM EST
20.71
-0.19 (-0.91%)
After-hours: Feb 27, 2026, 8:00 PM EST
Palatin Technologies Revenue
Palatin Technologies had revenue of $116.04K in the quarter ending December 31, 2025. This brings the company's revenue in the last twelve months to $8.96M, up 2,461.02% year-over-year.
Revenue (ttm)
$8.96M
Revenue Growth
+2,461.02%
P/S Ratio
3.96
Revenue / Employee
$309,089
Employees
29
Market Cap
35.46M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | - | - | - |
| Jun 30, 2024 | 4.49M | -363.59K | -7.49% |
| Jun 30, 2023 | 4.85M | 3.39M | 230.53% |
| Jun 30, 2022 | 1.47M | 1.66M | -878.62% |
| Jun 30, 2021 | -188.60K | -306.59K | -259.84% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Xilio Therapeutics | 31.80M |
| Veru Inc. | 16.89M |
| NovaBay Pharmaceuticals | 10.30M |
| CervoMed | 6.16M |
| Pluri | 1.34M |
| Lisata Therapeutics | 1.07M |
| INmune Bio | 50.00K |
PTN News
- 10 days ago - Palatin Technologies' Rare-Obesity Strategy Sets Up a Catalyst-Rich 2026 for Its MC4R Pipeline ... - GuruFocus
- 11 days ago - Palatin Technologies Inc (PTN) Q2 2026 Earnings Call Highlights: Strategic Advances Amid Rising ... - GuruFocus
- 11 days ago - Q2 2026 Palatin Technologies Inc Earnings Call Transcript - GuruFocus
- 11 days ago - Palatin Technologies, Inc. (PTN) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Palatin Technologies GAAP EPS of -$2.86 misses by $0.51, revenue of $0.11M beats by $0.09M - Seeking Alpha
- 11 days ago - Palatin Reports Second Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update - PRNewsWire
- 6 weeks ago - Palatin Technologies Targets Hypothalamic Obesity as Next Frontier Beyond GLP-1s (NYSE: PTN) - GuruFocus
- 2 months ago - JANUS HENDERSON GROUP PLC Acquires Shares in Palatin Technologies Inc - GuruFocus